Bevacizumab in the treatment of ovarian cancer
Ramez N Eskander1, Leslie M Randall21Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange, CA, USA; 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, U...
Enregistré dans:
Auteurs principaux: | Ramez N Eskander, Leslie M Randall |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eaf2adb7d17f4ca08eb11d5ecfccd55d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bevacizumab in the treatment of HER2-negative breast cancer
par: Vito Lorusso
Publié: (2008) -
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
par: Jia Li, et autres
Publié: (2009) -
Bevacizumab in the therapy for refractory metastatic colorectal cancer
par: Mary F Mulcahy
Publié: (2008) -
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
par: Twu C, et autres
Publié: (2012) -
Ovarian cancer: emerging molecular-targeted therapies
par: Sourbier C
Publié: (2012)